Japanese Red Cross to Use Roche Nucleic Acid Tools to Scan Blood Supply for HIV, HBV, HCV | GenomeWeb
NEW YORK (GenomeWeb News) — The Japanese Red Cross will use Roche’s PCR-based testing devices to screen the nation’s supply of donated blood for HIV and hepatitis B and C, the company said today.
 
Roche said it will supply next-generation nucleic acid-screening products to accommodate Japan’s 5 million annual blood donations. The tools will comprise Roche’s Cobas 401 and its TaqScreen MPX test, which can detect HIV-1, HIV-2, and hepatitis B and C viruses.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.